Founded in 1995 by Blackstone and U.S. Treasury veteran Roger Altman, independent investment banking advisory firm Evercore went public in August 2006 with an $83 million initial public offering. Since then, the firm has grown into an elite independent investment banking advisory firm, employing more 1,400 people and serving clients around the world from its 28 offices in North America, Europe, South America, and Asia. It also has alliances in Argentina, Australia, China, India, Japan and South Korea. 

The firm's investment banking business advises its clients on mergers, acquisitions, divestitures, restructurings, financings, public offerings, private placements, and other strategic transactions. It also provides institutional investors with equity research and sales and trading execution that is free of the conflicts created by proprietary activities.

To date, the firm has advised on more than $2.0 trillion of merger, acquisition, recapitalization, and restructuring transactions. Recent M&A assignments include advising DuPont on its $68 billion merger of equals with The Dow Chemical Company; EMC on its $67 billion sale to Dell and its owners: Michael S. Dell, MSD Capital, and Silver Lake; Shire plc on its $34.9 billion acquisition of Baxalta Incorporated; and Abbott Laboratories on its $31 billion acquisition of St. Jude Medical. The firm also offers investment management services to high net worth and institutional investors. 

Evercore is led by Roger Altman, its founder and executive chairman, and Ralph Schlosstein, its president and CEO, who for almost 20 years served as the president of BlackRock, the largest asset management firm in the world, which he co-founded in 1988.